A therapy based on messenger RNA (mRNA), a genetic material actively studied for vaccines and other applications, has turned back the 'aging clock' of immune T cells. Rejuvenated T cells can enhance i ...

Innovation Center of NanoMedicine (Center Director: Prof. Kazunori Kataoka) has announced that Prof. Satoshi Uchida (Principal Research Scientist), who is also Associated Professor of the Kyoto ...

The mRNA-based vaccines that turned the tide of the COVID-19 pandemic currently account for almost all the value of the mRNA vaccine/therapeutic market. Indeed, the vaccine-led response to the ...

CAMBRIDGE, Mass., August 28, 2025 – Raina Biosciences Inc., (“Raina”), an mRNA technology and therapeutics company, today announced the publication of data from its generative AI platform in Science.

As the COVID-19 pandemic began to wreak havoc on the world in 2020, the biopharmaceutical industry started working tirelessly to develop a vaccine to stop this global threat. Emerging from this effort ...

STONY BROOK, NY / ACCESSWIRE / August 23, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the filing with the ...

CRDMO capabilities are tailored for a full range of mRNA applications, including small-scale quantities for personalized cancer vaccines (PCVs) EMERYVILLE, Calif.--(BUSINESS WIRE)--=Nutcracker ...

This new, integrated service helps scientists accelerate their mRNA research projects by providing an integrated workflow across gene synthesis, plasmid preparation and DNA linearization, and mRNA ...

"Many New mRNA Applications." This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even ...

Raina Biosciences Inc., ("Raina"), an mRNA technology and therapeutics company, today announced the publication of data from its generative AI platform in Science. The data supports Raina's pioneering ...